About InferMed
InferMed is a Healthcare company based in London (United Kingdom) founded in 1999, and was acquired by Elsevier in July 2015. Decision support tools for healthcare users are offered by InferMed. The company was acqui-hired. Its focus areas include HealthTech, Healthcare IT, Provider and Clinical Operations. Its legal entity is INFERMED LIMITED.
Company details
InferMed was founded in 1999 and is based in London, United Kingdom. Tools for decision support in the healthcare sector are provided, including Arezzo Pathways, which integrates with primary care systems and analyzes patient records to deliver practice guidance. MACRO serves as an electronic tool for study definition, data capture, and management. Additional services assist with MACRO installation, configuration, and workflow integration.
- Headquarters London, United Kingdom
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Website infermed.com
- Social LinkedIn X
- Acquired by Elsevier (Jul 2015)
- Legal Name Infermed Limited
Investors in InferMed
InferMed has secured backing from 1 investor. Prominent investors backing the company include Elsevier.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Information solutions for science, health, and technology professionals are provided. | 1880 | elsevier.com | Amsterdam, Netherlands |
Investor details for InferMed
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of InferMed
2 dated milestones of InferMed across 16 years, from founding to its latest funding, stage changes and deals.
- Founded InferMed is founded.
- Exit Acquired by Elsevier.
Web traffic of InferMed
Websites that share an audience with InferMed (infermed.com).
Websites whose visitors overlap most with InferMed. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| ninepointmedical.com | 99% | View details | |||
| mapofmedicine.com | 79% | View details | |||
| mdxhealth.com | 62% | 15.2K | #1,948,837 | View details | |
| ichorms.com | 45% | 5.3K | #8,265,520 | View details |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about InferMed
InferMed was founded in 1999.
InferMed is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
Annual revenue of InferMed is $685.69K as on Dec 31, 2016.
InferMed was founded in 1999 and is based in London, United Kingdom. Tools for decision support in the healthcare sector are provided, including Arezzo Pathways, which integrates with primary care systems and analyzes patient records to deliver practice guidance. MACRO serves as an electronic tool for study definition, data capture, and management. Additional services assist with MACRO installation, configuration, and workflow integration.
InferMed has 1 investor. Key investors include Elsevier.
InferMed operates through Infermed Limited.
Yes. InferMed was acquired by Elsevier in July 2015.